EVOKE PHARMA, INC. Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
EVOKE PHARMA, INC. had Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount of $700.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized · last filed 2025-11-13
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $700.00K.
- 2025-06-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $800.00K.
- 2025-03-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $900.00K.
- 2024-12-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $0.50.
| Period end | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount |
|---|---|
| 2025-09-30 | $700.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $800.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $900.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $0.50 10-K · filed 2025-03-13 |
| 2024-09-30 | $700.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $300.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $400.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $1.10M 10-K/A · filed 2024-05-14 |
| 2023-09-30 | $1.30M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.60M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $1.80M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.80M 10-K · filed 2023-03-21 |
| 2022-09-30 | $2.20M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $2.50M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $2.70M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $2.90M 10-K · filed 2022-03-08 |
| 2021-09-30 | $3.60M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $4.00M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $4.30M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $2.00M 10-K · filed 2021-03-11 |
| 2020-09-30 | $2.50M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $2.90M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $2.20M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $2.10M 10-K · filed 2020-03-12 |
| 2019-09-30 | $2.40M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $2.70M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $2.90M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $1.80M 10-K · filed 2019-03-06 |
| 2018-09-30 | $2.20M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $2.50M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $2.50M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $1.70M 10-K · filed 2018-03-07 |
| 2017-09-30 | $2.10M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $2.20M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $2.60M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $1.80M 10-K · filed 2017-03-15 |
| 2016-09-30 | $2.20M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $2.60M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $2.70M 10-Q · filed 2016-05-11 |
| 2015-12-31 | $2.30M 10-K · filed 2016-03-10 |
| 2015-09-30 | $2.70M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $3.00M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $3.20M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $2.32M 10-K · filed 2015-03-04 |
| 2014-09-30 | $2.60M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $2.90M 10-Q · filed 2014-08-13 |
| 2014-03-31 | $2.90M 10-Q · filed 2014-05-13 |
| 2013-12-31 | $3.06M 10-K · filed 2014-03-25 |
| 2013-09-30 | $833.75K 10-Q · filed 2013-11-13 |
| 2012-12-31 | $26.00K 10-K · filed 2014-03-25 |